Microglia: Structure and Function in CNS Inflammation

Added:

Microglial Senescence (Dystrophy) and Loss of Function vs. Active Neuroinflammation

While traditional paradigms view microglia primarily as active, inflammatory instigators of neurodegeneration, an alternative perspective argues that age-related microglial senescence and dystrophy—characterized by a loss of protective, homeostatic functions—are the true drivers of central nervous system pathology. This viewpoint suggests that microglial 'exhaustion' prevents these cells from performing critical maintenance duties, such as synaptic pruning, trophic factor secretion, and debris clearance. Rather than being hyperactive, destructive inflammatory agents, senescent microglia leave the aging brain vulnerable to degeneration through functional neglect and a failure to maintain homeostasis. Furthermore, modern single-cell transcriptomics has largely debunked the binary M1/M2 (pro- vs. anti-inflammatory) polarization model, revealing that microglial states are highly heterogeneous and context-dependent, often performing essential neuroprotective roles even within inflammatory environments.

Basic neuroanatomy and cellular organization of the Central Nervous System (CNS), distinguishing between neurons and glial cells.
Fundamentals of immunology, specifically the mechanisms of the innate immune response, inflammation, phagocytosis, and antigen presentation.
The concept of the Blood-Brain Barrier (BBB) and the immunological privilege of the brain.
General cell biology concepts, including receptor-ligand interactions, phagocytic vesicle pathways, and lysosomal degradation.
The role of chronic microglial activation (microgliosis) in the pathogenesis of neurodegenerative diseases like Alzheimer's, Parkinson's, and Multiple Sclerosis.
The physiological process of synaptic pruning by microglia during neurodevelopment and its implications for synaptic plasticity.
The dual phenotypes of microglia (pro-inflammatory/classical vs. anti-inflammatory/alternative activation states) and their shifting paradigms in current research.
Pharmacological and therapeutic targeting of neuroinflammatory pathways, specifically modulating microglial responses to treat CNS disorders.
123K views848likes5:27@khanacademymedicineOriginal Release: 2013-09-24

Microglia are small glial cells of the central nervous system derived from mesodermal monocytes, existing in two states: resting microglia with branched processes that sample interstitial fluid for trouble, and active microglia that transform into amoeba-like shapes to combat inflammation, pathogens, and cellular debris through phagocytosis, cytotoxic factor secretion, and antigen presentation to immune cells.